Mycoplasma Diagnostics Testing Have Revolutionized With the Advent of Real-Time PCR Technology

 

Mycoplasma Diagnostics Market

The tests for Mycoplasma infections are based on the culture of bacterial cells. The culture is performed on a sample of urine, urethra, and vaginal secretions. Positive cultures are a sign of a Mycoplasma infection, yet, it may not mean a definitive diagnosis. Mycoplasmas are a severe problem for cattle and can have significant economic and welfare impacts. Thus, it is important to perform Mycoplasma diagnostics promptly to prevent outbreaks and minimize costs. PCR-based methods are more sensitive and specific than conventional culture-based methods and provide rapid diagnostic results.

Mycoplasma genitalium is a sexually transmitted infection. It is a common cause of persistent urethritis. A polymerase chain reaction test can detect Mycoplasma genitalium. Using this test, physicians can identify the presence of the infection and provide the most accurate treatment possible.

Real-time PCR technology has revolutionized Mycoplasma Diagnostics testing for infections. It is fast, inexpensive, and has high sensitivity. It also can identify the organism without culture, making it a popular option in veterinary practice. Moreover, PCR assays have been developed for four pathogenic avian mycoplasmas. The earliest assays targeted the 16S rRNA gene, a region that is highly conserved. This type of test has high sensitivity and cross-reactivity with other species of mollicutes.

Fortunately, there are two primary methods for detecting Mycoplasma hyopneumoniae in humans. One method uses a fluorescent antibody that binds to the organism. The other is an immunohistochemistry test that can detect the organism in fixed tissue. The latter is often more practical for obtaining samples in the field, while the former is more useful for detecting the disease in its early stages. Recently in July 2020, bioMérieux, a globally leading in vitro diagnostics company introduced BIO FIRE MYCOPLASMA, a new test for detection of mycoplasma in pharmaceutical products that are used in biotherapeutics.

For More Details about Mycoplasma Diagnostics Testing @ https://www.einnews.com/pr_news/556542384/mycoplasma-diagnostics-market-huge-growth-in-future-scope-2021-2028-agilent-technologies-american-type-culture


Comments

Popular posts from this blog

There are several advantages and even life-saving effects associated with Big Data in Healthcare.

Roofing Chemicals; aid in maintaining the lower temperature in the interiors of the buildings by reflecting the sunlight on the roofs

An electroencephalography (EEG) device measures and records electrical activity in the brain